Alliance Pharma (LSE:APH) 3-Year ROIIC % : -24.01% (As of Dec. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Alliance Pharma's 3-Year ROIIC % for the quarter that ended in Dec. 2022 was -24.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Alliance Pharma's 3-Year ROIIC % or its related term are showing as below:

LSE:APH's 3-Year ROIIC % is ranked worse than
74.95% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 1.21 vs LSE:APH: -24.01

Alliance Pharma 3-Year ROIIC % Historical Data

The historical data trend for Alliance Pharma's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma 3-Year ROIIC % Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

3-Year ROIIC %

Get a 7-Day Free Trial

9.15

14.91

-6.45

-32.17

-24.01

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
3-Year ROIIC %	Get a 7-Day Free Trial															-	-32.17	-	-24.01	-

Competitive Comparison of Alliance Pharma's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's 3-Year ROIIC % falls into.

Alliance Pharma 3-Year ROIIC % Calculation

Alliance Pharma's 3-Year ROIIC % for the quarter that ended in Dec. 2022 is calculated as:

3-Year ROIIC %	=	3-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	3-Year Incremental Invested Capital^**
	=	( 5.1758991 (Dec. 2022) - 30.365104 (Dec. 2019) )	/	( 481.682 (Dec. 2022) - 376.787 (Dec. 2019) )
	=	-25.1892049	/	104.895
	=	-24.01%^***

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Alliance Pharma (LSE:APH) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Alliance Pharma 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » 3-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).